Atlas Trials

Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer

Clinical trial NCT02260817 · COMPLETED

Trial details

NCT number
NCT02260817
Sponsor
Global Isotopes, LLC d/b/a Zevacor Molecular
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Metastatic Prostate Cancer
Start date
2014-10-01
Primary completion
2016-06-01
Enrollment
109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.